Freeline Therapeutics Holdings plc
FRLN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $28 | $71 | $258 | $114 |
| - Cash | $47 | $118 | $230 | $74 |
| + Debt | $6 | $0 | $0 | $0 |
| Enterprise Value | -$13 | -$47 | $28 | $41 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EBITDA | -$97 | -$133 | -$85 | -$52 |
| % Margin | – | – | – | – |
| Net Income | -$89 | -$140 | -$96 | -$54 |
| % Margin | – | – | – | – |
| EPS Diluted | -22.52 | -58.98 | -102.09 | -127.39 |
| % Growth | 61.8% | 42.2% | 19.9% | – |
| Operating Cash Flow | -$78 | -$108 | -$95 | -$52 |
| Capital Expenditures | -$7 | -$4 | -$3 | -$3 |
| Free Cash Flow | -$85 | -$112 | -$97 | -$55 |